last I heard it was resolved and an issue with the manufacturer doing the synthetic for first time. waiting on ethics approval to start again, with a drop of the low dose arm (that had to be there due to start low and slow but now had data) - focus was always the larger dose arm.
company needs to give an update to clarify.
Ann: Company Overview and Strategic Update, page-5
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.72M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 462190 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 237156 | 1 |
View Market Depth
| Last trade - 10.52am 20/08/2024 (20 minute delay) ? |
| EMD (ASX) Chart |
Day chart unavailable